Literature DB >> 1589143

GM1 ganglioside reduces ischemia-induced excitatory amino acid output: a microdialysis study in the gerbil hippocampus.

G Lombardi1, F Moroni.   

Abstract

The effects of transient forebrain ischemia on the extracellular concentration of the excitatory amino acids glutamate and aspartate were studied in the gerbil hippocampus using microdialysis. Bilateral carotid occlusion (8 min) increased glutamate and aspartate concentration in the dialysate by 3- to 8-fold. This increase lasted 20-30 min. When the animals were pretreated with GM1 ganglioside (30 mg/kg/day, i.p., for 3 days), the ischemia induced increase of excitatory amino acids in the dialysate was significantly reduced. The results are in line with the hypothesis that systemic GM1 ganglioside administration may reduce ischemia-induced brain damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1589143     DOI: 10.1016/0304-3940(92)90509-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Effects of metabotropic glutamate receptor stimulation on blood-brain barrier permeability during focal cerebral ischemia.

Authors:  Xia Liu; Oak Z Chi; Harvey R Weiss
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

Review 2.  Limiting neurological damage after stroke: a review of pharmacological treatment options.

Authors:  S J Read; T Hirano; S M Davis; G A Donnan
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

3.  Metabotropic glutamate receptors, transmitter output and fatty acids: studies in rat brain slices.

Authors:  G Lombardi; P Leonardi; F Moroni
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

4.  The Neuroprotective Effects of mGlu1 Receptor Antagonists Are Mediated by an Enhancement of GABAergic Synaptic Transmission via a Presynaptic CB1 Receptor Mechanism.

Authors:  Elisa Landucci; Rolando Berlinguer-Palmini; Gilda Baccini; Francesca Boscia; Elisabetta Gerace; Guido Mannaioni; Domenico E Pellegrini-Giampietro
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.